Does a positive pretransplant crossmatch affect long-term outcome in liver transplantation?

Authors
Al-Sibae, Mohamad R
Koffron, Alan J
Raofi, Vandad
Affiliation
Division of Transplant and Hepatobiliary Surgery, William Beaumont, Hospital/Oakland University Medical School, Royal Oak, MI 48073, USA.
Issue Date
2012-02-01T10:02:05Z
MeSH
Graft Rejection/immunology/prevention & control
Hepatitis C/*surgery
*Histocompatibility Testing
Humans
Liver Transplantation/*immunology
Treatment Outcome

Metadata
Show full item record
Citation
Transplantation. 2011 Feb 15;91(3):261-2.
Journal
Transplantation
URI
http://hdl.handle.net/10147/207212
DOI
10.1097/TP.0b013e318204758c
PubMed ID
21107302
Abstract
Despite the historical success of liver transplantation in the face of a positive lymphocytic crossmatch, increased incidence of acute cellular rejection and graft loss have been reported in this setting. Given the potential adverse effects of antirejection treatment, especially in hepatitis C virus-positive recipients, identification of predisposing factors could allow for better surveillance, avoidance of rejection, and potentially better graft outcomes.
Language
eng
ISSN
1534-6080 (Electronic)
0041-1337 (Linking)
Collections